Publications

Filters
September 17, 2020

Safety and efficacy of Xevinapant (Debio 1143), an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in…

Read more
August 3, 2020

Afabicin, a first-in-class anti-staphylococcal antibiotic, in the treatment of acute bacterial skin and skin structure infections: clinical non-inferiority to vancomycin/linezolid

Read more
August 3, 2020

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind,…

Read more
May 29, 2020

Final results from the Phase I study expansion cohort of the selective FGFR inhibitor Debio 1347 in patients with solid…

Read more
September 24, 2019

Debio 1143 Mode of Action: a Broad Chemo-Radio and Immuno-Therapy Sensitizer

Read more
September 24, 2019

Squamous Cell Carcinoma Of The Head & Neck (SCCHN) – Infographic

Read more
September 19, 2019

Cholecystokinin-2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma – Results of the Lumed Phase 0a Study

Read more
July 4, 2019

DEBIO 1347 In Patients With GastroIntestinal Cancers Harboring An FGFR Gene Fusion: Preliminary Results

Read more
June 1, 2019

A dose-finding study of the SMAC mimetic Debio 1143 when given in combination with avelumab to patients with advanced solid…

Read more